Principles of the Procedure

  • LumiraDx SARS-CoV-2 RNA STAR is a molecular test kit, which reduces the amplification step of the PCR process from approximately one hour to 12 minutes.
  • This Fast Lab Solution utilizes LumiraDx’s innovative qSTAR amplification technology in an accessible high-throughput format in open molecular systems to improve efficiency and speed. 
  • qSTAR (quantitative Selective Temperature Amplification Reaction) uses a non-isothermal nucleic acid amplification technique that qualitatively detects RNA from SARS-CoV-2 (COVID-19).
  • This Test has been validated from common upper respiratory tract specimens in Universal Transport Medium (UTM).

Test Description

  • Patient sample is collected and purified through standard automated or manual extraction processes.
  • The sample is then added to the Reagent Mix where it is transcribed to cDNA.
  • If present in the sample, SARS-CoV-2 nucleic acids will be amplified by qSTAR technology and results will be reported in approximately 12 minutes.

For more information about LumiraDx SARS-CoV-2 RNA STAR

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. LumiraDx SARS-CoV-2 RNA STAR is available in the US under FDA Emergency Use Authorization.